PHARM -- An open-label extension study of CM-AT in children with autism
Project Description:
This study examines the effects of supplementation with a digestive enzyme on autism symptoms and gastrointestinal distress. This portion is the open-label phase of the study.
Keyword(s):
autism, gastrointestinal distress, chymotrypsin
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
National
COVID-19 Related Data:
N/A